Drug Trial Radar · NCT07022483
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
710
Planned (sponsor's estimate)
Start
Sep 30, 2025
Primary completion
Feb 26, 2030
Study completion Mar 23, 2032
Sponsor
- Lead sponsor
- Daiichi SankyoDaiichi Sankyo (DSNKY)
- Sponsor type
- Industry
- Collaborators
- AstraZeneca
- First posted
- Jun 15, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to assess efficacy and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial cancer with various HER2 expression levels.
Conditions
- Endometrial Cancer
Interventions
Trastuzumab DeruxtecanDrug
T-DXd will be administered at a dose of 5.4 mg/kg IV Q3W.
ChemotherapyDrug
Carboplatin AUC 5 or 6 and paclitaxel will be administered at a dose of 175 mg/m2 Q3W, or carboplatin AUC 5 or 6 and paclitaxel 175 mg/m2 Q3W with or without radiation therapy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-Free Survival (DFS) as Assessed by Blinded Independent Central Review or by Histopathologic Confirmation of Disease Recurrence per Local AssessmentTime frame: From randomization to the first documented local regional recurrence, distant metastasis, or death due to any cause, whichever occurs first, up to approximately 51 months
Locations
86 sites in 15 countries. Site status is shown where the registry gives one.
Broward Health Medical Center
Fort Lauderdale, Florida · Recruiting
Miami Cancer Institute
Miami, Florida · Recruiting
Mount Sinai Medical Center
Miami Beach, Florida · Recruiting
AdventHealth
Orlando, Florida · Recruiting
Parkview Research Center
Fort Wayne, Indiana · Recruiting
Trials365 LLC
Shreveport, Louisiana · Recruiting
Minnesota Oncology Hematology, P.A.
Coon Rapids, Minnesota · Recruiting
FirstHealth of the Carolinas, Inc.
Pinehurst, North Carolina · Recruiting
University of Cincinnati Physicians Group, LLC
Cincinnati, Ohio · Recruiting
Western Pennsylvania Hospital
Pittsburgh, Pennsylvania · Recruiting
Avera Medical Group Gynecologic Oncology Sioux Falls
Sioux Falls, South Dakota · Recruiting
Texas Oncology, P.A. - Tyler
Sioux Falls, South Dakota · Recruiting
Texas Oncology - Bedford
Bedford, Texas · Recruiting
Texas Oncology San Antonio Medical Center
San Antonio, Texas · Recruiting
Hospital Italiano de Buenos Aires
Ciudad Autonoma Buenos Aires, Argentina · Recruiting
Sanatorio Allende Cerro
Córdoba, Argentina · Recruiting
Centro de Investigaciones Medicas Mar del Plata
Mar del Plata, Argentina · Recruiting
Instituto de Oncologia de Rosario
Rosario, Argentina · Recruiting
Instituto Medico de la Fundacion Estudios Clinicos
Rosario, Argentina · Recruiting
CER San Juan Centro Polivalente de Asistencia e Inv. Clinica
San Juan, Argentina · Recruiting
Biocenter
Concepción, Chile · Recruiting
Centro de Estudios Clinicos SAGA
Santiago, Chile · Recruiting
Centro de Investigaciones Clinicas de la Universidad Catolica
Santiago, Chile · Recruiting
Beijing Cancer Hospital
Beijing, China · Recruiting
The First Hospital of Jilin University
Changchun, China · Recruiting
West China Second University Hospital, Sichuan University
Chengdu, China · Recruiting
Obstetrics and Gynecology Hospital Affiliated to Zhejiang University School of Medicine
Hangzhou, China · Recruiting
Zhejiang Cancer Hospital
Hangzhou, China · Recruiting
Cancer Hospital of Shandong First Medical University
Jinan, China · Recruiting
Linyi Cancer Hospital
Linyi, China · Recruiting
Jiangxi Maternal and Child Health Hospital
Nanchang, China · Recruiting
Guangxi Medical University Affiliated Tumor Hospital
Nanning, China · Recruiting
Shanghai First Maternity and Infant HospitalShanghai First Maternity and Infant Hospital
Shanghai, China · Recruiting
Shanghai Tenth People's Hospital
Shanghai, China · Recruiting
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China · Recruiting
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, China · Recruiting
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, China · Recruiting
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, China · Recruiting
Yantai Yuhuangding Hospital
Yantai, China · Recruiting
Centre Francois Baclesse
Caen, France · Recruiting
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.